Follow
Ilan S. Schwartz
Title
Cited by
Cited by
Year
A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19
DR Boulware, MF Pullen, AS Bangdiwala, KA Pastick, SM Lofgren, ...
New England journal of medicine 383 (6), 517-525, 2020
15572020
Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial
CP Skipper, KA Pastick, NW Engen, AS Bangdiwala, M Abassi, ...
Annals of internal medicine 173 (8), 623-631, 2020
6402020
Emerging fungal infections: new patients, new patterns, and new pathogens
DZP Friedman, IS Schwartz
Journal of Fungi 5 (3), 67, 2019
2842019
Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19)
KA Pastick, EC Okafor, F Wang, SM Lofgren, CP Skipper, MR Nicol, ...
Open forum infectious diseases 7 (4), ofaa130, 2020
2352020
Re-drawing the maps for endemic mycoses
N Ashraf, RC Kubat, V Poplin, AA Adenis, DW Denning, L Wright, ...
Mycopathologia 185, 843-865, 2020
2012020
Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales)
K Dukik, JF Muņoz, Y Jiang, P Feng, L Sigler, JB Stielow, J Freeke, ...
Mycoses 60 (5), 296-309, 2017
1392017
Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International …
GR Thompson, T Le, A Chindamporn, CA Kauffman, ...
The Lancet Infectious Diseases 21 (12), e364-e374, 2021
1182021
Coronavirus disease 2019–associated invasive fungal infection
JW Baddley, GR Thompson III, SCA Chen, PL White, MD Johnson, ...
Open forum infectious diseases 8 (12), ofab510, 2021
962021
High rates of influenza-associated invasive pulmonary aspergillosis may not be universal: a retrospective cohort study from Alberta, Canada
IS Schwartz, DZP Friedman, L Zapernick, TC Dingle, N Lee, W Sligl, ...
Clinical Infectious Diseases 71 (7), 1760-1763, 2020
952020
Phylogeny, ecology and taxonomy of systemic pathogens and their relatives in Ajellomycetaceae (Onygenales): Blastomyces, Emergomyces, Emmonsia, Emmonsiellopsis
Y Jiang, K Dukik, JF Muņoz, L Sigler, IS Schwartz, NP Govender, ...
Fungal Diversity 90, 245-291, 2018
832018
Clinical characteristics, diagnosis, management, and outcomes of disseminated emmonsiosis: a retrospective case series
IS Schwartz, NP Govender, C Corcoran, S Dlamini, H Prozesky, R Burton, ...
Clinical Infectious Diseases 61 (6), 1004-1012, 2015
832015
Blastomyces helicus, a New Dimorphic Fungus Causing Fatal Pulmonary and Systemic Disease in Humans and Animals in Western Canada and the United States
IS Schwartz, NP Wiederhold, KE Hanson, TF Patterson, L Sigler
Clinical Infectious Diseases 68 (2), 188-195, 2019
822019
Bacterial superinfections among persons with coronavirus disease 2019: a comprehensive review of data from postmortem studies
CJ Clancy, IS Schwartz, B Kula, MH Nguyen
Open Forum Infectious Diseases 8 (3), ofab065, 2021
812021
50 Years of Emmonsia Disease in Humans: The Dramatic Emergence of a Cluster of Novel Fungal Pathogens
IS Schwartz, C Kenyon, P Feng, NP Govender, K Dukik, L Sigler, Y Jiang, ...
PLoS pathogens 11 (11), e1005198, 2015
762015
Invasive mould disease in fatal COVID-19: a systematic review of autopsies
BE Kula, CJ Clancy, MH Nguyen, IS Schwartz
The Lancet Microbe 2 (8), e405-e414, 2021
742021
Outbreak Detection: First reported case of multidrug-resistant Candida auris in Canada
IS Schwartz, GW Hammond
Canada Communicable Disease Report 43 (7-8), 150, 2017
742017
Effects of sexual network connectivity and antimicrobial drug use on antimicrobial resistance in Neisseria gonorrhoeae
CR Kenyon, IS Schwartz
Emerging Infectious Diseases 24 (7), 1195, 2018
722018
Emergomyces: The global rise of new dimorphic fungal pathogens
IS Schwartz, NP Govender, L Sigler, Y Jiang, TG Maphanga, B Toplis, ...
PLoS Pathogens 15 (9), e1007977, 2019
602019
Defining COVID-19–associated pulmonary aspergillosis: systematic review and meta-analysis
RM Kariyawasam, TC Dingle, BE Kula, B Vandermeer, WI Sligl, ...
Clinical Microbiology and Infection 28 (7), 920-927, 2022
592022
Safety of hydroxychloroquine among outpatient clinical trial participants for COVID-19
SM Lofgren, MR Nicol, AS Bangdiwala, KA Pastick, EC Okafor, ...
Open forum infectious diseases 7 (11), ofaa500, 2020
582020
The system can't perform the operation now. Try again later.
Articles 1–20